CD38 and hepatocellular carcinoma: For instance, CD38 has been identified as a co-exhaustion marker in CD8+ tissue-resident memory T cells in hepatocellular carcinoma (HCC), correlating with increased PD-1 expression and higher histopathological grades (Reolo et al., 2023).